MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, SPRB had $5,174K increase in cash & cash equivalents over the period. -$8,742K in free cash flow.

Cash Flow Overview

Change in Cash
$5,174K
Free Cash flow
-$8,742K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from debt, gross
    • Prepaid expenses and other curre...
    • Accounts payable
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Accrued expenses and other curre...
    • Payment of debt and equity offer...
    • Others

Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net loss
-12,266 -14,646 -24,320 -
Stock-based compensation expense
689 1,692 882 -
Depreciation and amortization
252 5 16 -
Non-cash lease expense
71 69 199 -
Loss on disposal of property and equipment
-0 0 -
Change in fair value of warrant and conversion option liabilities
91 4,017 -517 -
Prepaid expenses and other current assets
-2,054 -841 -1,606 -
Other assets
-64 0 0 -
Accounts payable
1,700 -443 91 -
Accrued expenses and other current liabilities
-1,300 1,808 -4,310 -
Deferred revenue
-0 0 -
Other liabilities
-87 201 -518 -
Net cash used in operating activities
-8,732 -6,456 -26,871 -
Proceeds from exercise of pre-funded warrants
-40 --
Purchases of property and equipment
10 ---
Proceeds from exercise of common stock options
-5 0 -
Proceeds from issuance of common stock and warrants
-50,000 --
Net cash used in investing activities
-10 ---
Proceeds from issuance of common stock related to employee stock purchase plan
-22 3 -
Proceeds from debt, gross
14,146 ---
Repayment of debt
0 841 1,216 -
Payment of debt and equity offering costs
220 3,701 --
Tax withholding payments on restricted stock units
10 831 0 -
Net cash provided by (used in) financing activities
13,916 44,694 -1,213 -
Restricted cash
---35
Net increase (decrease) in cash, cash equivalents, and restricted cash
5,174 38,238 -28,084 -
Cash and cash equivalents, at carrying value, ending balance
---16,387
Cash, cash equivalents, and restricted cash at beginning of period
48,942 10,704 16,422 -
Cash, cash equivalents, and restricted cash at end of period
54,116 48,942 10,704 16,422
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from debt, gross$14,146K Net cash provided by(used in) financing...$13,916K Canceled cashflow$230K Net increase(decrease) in cash, cash...$5,174K Canceled cashflow$8,742K Payment of debt andequity offering costs$220K Tax withholdingpayments on restricted...$10K Prepaid expenses andother current assets-$2,054K Accounts payable$1,700K Stock-based compensationexpense$689K Depreciation andamortization$252K Change in fair value ofwarrant and conversion...$91K Non-cash lease expense$71K Other assets-$64K Net cash used inoperating activities-$8,732K Net cash used ininvesting activities-$10K Canceled cashflow$4,921K Net loss-$12,266K Purchases of property andequipment$10K Accrued expenses andother current...-$1,300K Other liabilities-$87K

SPRUCE BIOSCIENCES, INC. (SPRB)

SPRUCE BIOSCIENCES, INC. (SPRB)